Clinical Trials in Shaoguan, China
4 recruiting
Showing 1–20 of 22 trials
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer (Early Breast Cancer)
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled452 locationsNCT06531824
Recruiting
Phase 3
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
ANCA Associated Vasculitis (AAV)
Staidson (Beijing) Biopharmaceuticals Co., Ltd300 enrolled60 locationsNCT07168161
Recruiting
Phase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Eli Lilly and Company1,431 enrolled251 locationsNCT07415044
Recruiting
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Hepatocellular Carcinoma Resectable
Zhujiang Hospital255 enrolled7 locationsNCT06157060
Recruiting
Phase 1Phase 2
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Solid Tumor
Advenchen Laboratories, LLC228 enrolled15 locationsNCT07392736
Recruiting
Phase 3
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Gastric Cancer (GC)Adjuvant ChemotherapyOxaliplatin+2 more
Ruijin Hospital387 enrolled5 locationsNCT07366528
Recruiting
Not Applicable
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital96 enrolled24 locationsNCT07136792
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Not Applicable
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
Gastric NeoplasmsGastric UlcerGastric Lesion+3 more
Nanfang Hospital, Southern Medical University482 enrolled12 locationsNCT06848400
Recruiting
Phase 3
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Triple Negative Breast Cancer(TNBC)
Biotheus Inc.360 enrolled70 locationsNCT06419621
Recruiting
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns
Metastatic Breast Cancer
Sun Yat-sen University800 enrolled23 locationsNCT06551220
Recruiting
Not Applicable
Thrombus Aspiration in STEMI Patients With High Thrombus Burden
ST-segment elevation myocardial infarction (STEMI)
Guangdong Provincial People's Hospital3,838 enrolled50 locationsNCT04212494
Recruiting
Phase 3
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Akeso420 enrolled59 locationsNCT06383468
Recruiting
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University718 enrolled10 locationsNCT06308328
Recruiting
Phase 3
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Cancer+1 more
Sun Yat-sen University388 enrolled6 locationsNCT04453826